Prostate-Specific Membrane Antigen (PSMA) PET-CT: Revolutionizing Staging, Restaging, and Treatment Response Assessment
Prostate-specific membrane antigen (PSMA) positron emission tomography–computed tomography (PET-CT), has become the benchmark imaging tool in the management of prostate cancer, due to its unparalleled precision in staging, restaging and assessing of treatment response. Traditional imaging modalities...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Asian Medical Press Ltd.(H.K.)
2025-12-01
|
| Edice: | Annals of Urologic Oncology |
| Témata: | |
| On-line přístup: | https://auo.asmepress.com/articles/new-42-985.html |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|